BioStock: Doubled sales and an improved position for PHI

In the year-end report for 2021/2022, Phase Holographic Imaging highlights the increased sales, the investment in regenerative medicine and the patent awarded for synthetic antibodies. The company reports doubled sales and is ready to deliver the new addition to the company’s product range during the autumn.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/07/doubled-sales-and-an-improved-position-for-phi/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/